Clinical Trial Detail

NCT ID NCT03006848
Title A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

osteosarcoma

Therapies

Avelumab

Age Groups: adult child

No variant requirements are available.